Prochymal®, mesenchymal stem cells for treatment of Crohn's disease
Prochymal® is an intravenously administered formulation of mesenchymal stem cells, and is being evaluated in Phase 3 clinical trials for the treatment of moderate to severe Crohn's disease.
Read More
Product Information for
Prochymal®, mesenchymal stem cells for treatment of Crohn's disease
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access